DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics Market" report has been added to ResearchAndMarkets.com's offering.
A recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032.
The study offers a comprehensive assessment of the more important market dynamics.
After conducting thorough research on the historical and current growth parameters of the In Vitro Diagnostics Market, the growth prospects of the market are obtained with maximum precision.
Key Players
- Thermo Fischer Scientific Inc.
- Abbott Laboratories
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche AG
- Siemens Healthineers AG
- BD (Becton, Dickinson, and Company)
- Seegene Inc.
- DiaSorin S.p.A.
- Quest Diagnostics Incorporated
Market Segmentation
The In Vitro Diagnostics Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Product & Service
- Reagents
- Instruments
- Services & software
By Technology
- Immunodiagnostics
- Hematology
- Molecular diagnostics
- Tissue diagnostics
- Clinical chemistry
- Others
By Application
- Infectious diseases
- Cancer
- Cardiac diseases
- Immune system disorders
- Nephrological diseases
- Gastrointestinal diseases
- Others
By End User
- Standalone laboratories
- Hospitals
- Academics & Medical Schools
- Point-of-Care
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
For more information about this report visit https://www.researchandmarkets.com/r/2uof78
